Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 96 results for "julie masow"

Novartis recognized as top ranking company in the US on DiversityInc Top 50 Companies for Diversity list
Scottrade

Novartis recognized as top ranking company in the US on Divers...

/PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) has been named the leading company on the 14th annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2014 Top 50 Companies for Diversity on ... TickerTech.com, 17 hours ago
[x]  

Glaxo deals shift company's focus to vaccines, consumer products

With a trio of transactions, GlaxoSmithKline PLC Chief Executive Officer Andrew Witty is expanding the U.K. pharmaceutical company's positions in consumer products and vaccines, providing "durability" as the industry faces increased pricing pressure ...
 Denver Post21 hours ago

Novartis data on 19 compounds at AACR highlight strong cancer pipeline across multiple molecular targets and biological pathways

/PRNewswire/ --Novartis announced today that early stage data on 19 investigational compounds in its oncology pipeline will be presented at the annual meeting of the American Association of Cancer Research (AACR), April 5-9, 2014 in San Diego, CA.
 Asian Hospital & Healthcare Management2 weeks ago Novartis AG Shows Off A Strong Pipeline Of 19 New Compounds At American Association for Cancer Research  BioSpace2 weeks ago
[x]  

Teva Gets High Court Hearing on Generic Copaxone Delay

(Updates with Novartis comment in eighth paragraph.) March 31 (Bloomberg) -- The U.S. Supreme Court agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. in a move that may delay generic competition to its top-selling Copaxone ...
 Washington Post3 weeks ago Teva Gets U.S. High Court Hearing on Generic Copaxone Delay  Washington Post3 weeks ago

Novartis study published in NEJM showed LDK378 demonstrated an overall response rate of 58% in patients …

/PRNewswire/ --Novartis today announced that The New England Journal of Medicine (NEJM) published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate (ORR, including complete response ...
 Yahoo! Finance4 weeks ago Novartis reports new Phase III data showing secukinumab (AIN457) improved moderate-to-severe plaque psoriasis in patients  Reuters1 month ago Novartis Announces FDA Approval of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form …  Yahoo! Finance1 month ago Novartis AG Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives  BioSpace1 month ago
[x]  
NBCNews.com

College Student's Death Renews Call for Vaccine

As a Pittsburgh family prepares to bury a 19-year-old Drexel University student who died suddenly of a fast-moving infection, a drugmaker says it will seek U.S. approval for a meningitis vaccine that may have saved her. Officials with Novartis ...
 NBCNews.com1 month ago College Student's Death Sparks Call for Wider Use of Vaccine  NBCNews.com1 month ago
EuroInvestor

Novartis ruft im Rahmen des "Rare Disease Day" dazu auf, mehr in die Forschung von seltenen Krankheiten zu investieren -

Weltblick 28.02.07:40 SMI 8.470,90 -0,73% SPI 8.147,58 -0,07% DAX 9.588,33 -0,76% MDAX 16.826,88 -0,16% TecDax 1.262,09 -0,56% EuStoxx 3.134,94 -0,42% EUR/$ 1,37 -0,09% EUR/CHF 1,22 -0,03% USD/CHF 0,89 0,07% Novartis N Last Zeit ...
 Quoteline1 month ago Novartis marks Rare Disease Day with call for more research to understand and find treatments for rare  Yahoo! Finance1 month ago Novartis AG : Novartis marks Rare Disease Day with call for more research to understand and find treatments for rare diseases »  4 Traders1 month ago
[x]  

Novartis provides second US university with Bexsero®

CAMBRIDGE, Mass., Feb. 24, 2014 /PRNewswire/ -- Novartis announced today that its meningococcal serogroup B (MenB) vaccine, Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]), will be used as part of a vaccination program at the ...
 Yahoo! Singapore1 month ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less